Serum protein alterations in dogs naturally infected with Toxoplasma gondii

Alanine Transaminase 04 agricultural and veterinary sciences 3. Good health 0403 veterinary science Dogs Toxoplasmosis, Animal Animals Electrophoresis, Polyacrylamide Gel Serum Globulins Aspartate Aminotransferases Dog Diseases Serum Albumin
DOI: 10.1007/s00436-007-0601-0 Publication Date: 2007-07-21T14:04:02Z
ABSTRACT
We conducted this study to describe the serum electrophoretic pattern in dogs associated with the infection of Toxoplasma gondii (T. gondii). The serum protein pattern of 25 dogs with confirmed T. gondii infection and 15 clinically healthy dogs were evaluated using native polyacrylamide gel electrophoresis. Albumin, alpha-1 globulin, alpha-2 globulin, beta globulin, and gamma globulin bands were seen from the serum electrophoresis of infected and healthy dogs. Compared to the control group, significant decreases in the mean percentages of albumin (from 46.1+/-7.2 to 40.8+/-4.5%, P<0.05), alpha-1 globulin (from 3.9+/-0.4 to 0.8+/-0.2%, P<0.001), alpha-2 globulin (from 9.0+/-0.4 to 8.3+/-0.8%, P<0.01), and beta globulin (from 18.4+/-1.2 to 12.1+/-0.6%, P<0.001) in the infected group were determined. In contrast, gamma globulin fraction was significantly higher in infected dogs (38.1+/-4.6%) than in control dogs (22.7+/-7.2%; P<0.001). Moreover, significant correlations were determined between the percentages of the albumin and gamma globulin fractions and liver enzyme tests including aspartate aminotransferase and alanine aminotransferase in infected dogs; however, no correlation was observed for the other protein fractions. In conclusion, marked alterations in serum protein pattern associated with strong modifications of serum protein concentrations are in accordance with the hepatic injury as affirmed by liver enzyme tests that were demonstrated in the canine toxoplasmosis. These findings showed that serum protein electrophoresis can be used in the diagnosis and prognosis of canine toxoplasmosis as a supplementary analysis in combination with serological, clinical, and laboratory findings of this disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....